Universal Health Realty Income Trust (UHT) — Titan Protect Analysis

UHT

Universal Health Realty Income Trust

Real Estate · ·

$41.20

Data: 2026-06-03

✓ ETHICAL PASS

NONE MOAT

LIMITED

Data Confidence: 0.0%

Key Metrics

How this company measures up on the fundamentals that matter

Market Cap

$563M

Total market value of the company

Trailing P/E

31.70

Premium valuation

Forward P/E

N/A

Based on estimated future earnings — lower means cheaper

Rev Growth

+0.3%

Year-over-year revenue change

Profit Margin

17.7%

How much profit the company keeps from each dollar of revenue

ROE

11.2%

Return on equity — how efficiently it uses shareholder money

Analyst Target

$42.00

+2% from current price — median analyst estimate

Recommendation

NONE

Consensus view from 1 analysts covering this stock

About Universal Health Realty Income Trust

Universal Health Realty Income Trust, a real estate investment trust, invests in healthcare and human-service related facilities. It also includes acute care hospitals, behavioral health care hospitals, specialty facilities, medical/office buildings, free-standing emergency departments and childcare centers. They have investments in seventy-six properties located in twenty-one states. Universal Health Realty Income Trust was incorporated in 1986 and is based in King of Prussia, United States.

https://www.uhrit.com

Country: United States Industry: REIT - Healthcare Facilities

Ethical Screening

Five compliance checks based on AAOIFI standards — all must pass for ethical clearance

Business Activity

PASS

Core business does not involve prohibited activities

Debt Ratio

0.0% PENDING

Debt must be below 33% of total assets

Cash Ratio

0.0% PENDING

Interest-bearing cash below 33% of assets

Receivables

0.0% PENDING

Receivables below 49% of assets

Revenue Purity

0.0% PENDING

Non-compliant revenue below 5% — any excess requires purification

Quantitative Intelligence

Statistical analysis of price behaviour, risk, and market regime — independent of fundamental data

Regime

MARKDOWN

Price trending down — defensive positioning

Sharpe Ratio

0.568

Good returns relative to risk taken

Kelly Fraction

0.0336

Modest edge detected — smaller position warranted

Calmar Ratio

0.457

Drawdown risk outweighs the returns — higher risk profile

Annual Return

10.5%

Historical annualised return based on price data

Max Drawdown

-23.0%

Largest peak-to-trough decline — the worst it has been

HMM State

SIDEWAYS

Price consolidating — no clear directional bias

Days in State

How long the current regime has persisted — longer means more stable

Market Data

Trading characteristics and market positioning

Beta

0.85

Less volatile than the market — more defensive

52W High

$44.70

8% below the year high

52W Low

$35.26

17% above the year low

Avg Volume

64,384

Average daily shares traded — higher means easier to buy and sell

Short Ratio

6.7

Days it would take all short sellers to cover — higher means more crowded

Short % Float

N/A

Div Yield

734.0%

Annual dividend as a percentage of the share price

EPS (TTM)

$1.28

Earnings per share over the last 12 months

Financial Health

Balance sheet strength and cash generation — the foundation of long-term value

Debt/Equity

263.32

Heavy leverage — higher financial risk if revenues decline

Current Ratio

N/A

Quick Ratio

N/A

Like current ratio but excludes inventory — stricter test

Gross Margin

94.4%

Revenue left after cost of goods — higher means pricing power

Operating Margin

37.8%

Profit from core operations before interest and tax

Free Cash Flow

$47M

Positive — the business generates more cash than it spends

Revenue (TTM)

$101M

Total revenue over the last 12 months

Net Income

$18M

Profitable — the bottom line is positive

Analyst Coverage

Analysts

Target High

$42.00

Target Median

$42.00

Target Low

$42.00

Explore the Ethical Screener View Track Record

Data sourced from public filings and market feeds. Not financial advice. Updated: 2026-06-03

Before you go